# Pappas Capital: portfolio, investments and team > Pappas Capital is a vc firm based in United States. 12 investments on record, 2 in the last 12 months, latest Oct 2026. Source: https://millionrounds.com/fund/pappas-capital (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Pappas Capital Last cheque observed Oct 2026; 12 cheques on record. Email Deploying now VC firm Seed Series A Series B Molecules Pharmaceuticals Medicine Follow Pappas Capital and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fpappas-capital) Deploying now **100%** of best year **2** **cheques in 12 months**, 12 on record Since the last cheque **17** days **00** hrs **00** min **00** sec Median round **$52M** Rounds led **0 of 12** Mostly in **United States, 75%** Pitch Pappas Capital ## Pappas Capital highlights - 01 2 cheques in the last 12 months - 02 Mostly Series A and Series B: 91% of its rounds ## What they do > For 32 years Pappas Capital has been investing in and building innovative companies that are developing the next generation of life science products and technologies. From their own website - **Type:** VC firm (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B Growth - **Sectors:** Molecules Pharmaceuticals Medicine - **Based in:** Durham, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **12 appearances** - **2026** 2 rounds - **Oct** **[Altay Therapeutics, Inc.](https://millionrounds.com/company/altay-therapeutics-inc)** Series A · US · Sound Bioventures **$37M** With 5 others - **Sept** **[Breye Therapeutics](https://millionrounds.com/company/breye-therapeutics)** Series A · DK · Sound Bioventures **$77M** With 11 others - **2019** 1 round - **May** **[Reneo Pharmaceuticals](https://millionrounds.com/company/reneo-pharmaceuticals)** Series A · US · FinSMEs **$50M** With 3 others - **2018** 5 rounds - **Nov** **[Ribometrix](https://millionrounds.com/company/ribometrix)** Series A · US · FinSMEs **$30M** With 10 others - **Nov** **[Mirum Therapeutics](https://millionrounds.com/company/mirum-therapeutics)** Series A · US · FinSMEs **$120M** With 5 others - **Oct** **[Milestone Pharmaceuticals](https://millionrounds.com/company/milestone-pharmaceuticals)** CA · FinSMEs **$80M** With 9 others - **Oct** **[CuraSen](https://millionrounds.com/company/curasen)** Series A · US · FinSMEs **$55M** With 4 others - **Sept** **[4D Molecular](https://millionrounds.com/company/4d-molecular)** Series B · US · Endpts **$90M** With 9 others - **2017** 3 rounds - **Aug** **[Amplyx](https://millionrounds.com/company/amplyx)** Series C · US · FinSMEs **$67M** With 6 others - **Jul** **[Kezar Life Sciences](https://millionrounds.com/company/kezar-life-sciences)** Series B · US · FinSMEs **$50M** With 7 others - **Mar** **[Boragen](https://millionrounds.com/company/boragen)** Series A · US · FinSMEs **$10M** With 9 others - **Undated** 1 round - **-** **[VFlowTech](https://millionrounds.com/company/vflow-tech)** Series A · SG · Firms' own news pages **$10M** With 7 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **2 named** AM **Arthur M. Pappas** Officer i Form ADV MA **Matthew A. Boyer** Chief Financial Officer i Form ADV We also hold **8** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$165M** gross assets of its funds Oct 2026 **Exempt** reporting adviser venture or small private funds - **Legal name:** Pappas Capital, LLC - **SEC number:** CRD 163346 ## What they claim to have backed From their own portfolio page (on their website) **1** of 4 we have independently watched raise [bio](https://millionrounds.com/company/bio) NVCA Webtoffee nc-biotech Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. ## The cheque Seed Series A Series B Median round joined **$52M** the round, not its cheque Led 0 of 12 rounds **0%** - **Sole investor:** Never alone - **Last cheque:** Oct 2026 Rounds by stage said on their site - Series A said *8* - Series B said *2* - Series C *1* - Seed said *-* - Growth said *-* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) 2 - [Hatteras Venture Partners](https://millionrounds.com/fund/hatteras-venture-partners) 2 - [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 2 - [RiverVest](https://millionrounds.com/fund/rivervest-venture-partners) 2 - [Sound Bioventures](https://millionrounds.com/fund/sound-bioventures) 2 **Pitching Pappas Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Pappas Capital. A count of rooms they were both in, not a relationship either has claimed. [**Alexandria Real Estate Equities** VC firm **2** rounds together](https://millionrounds.com/fund/alexandria)[**Hatteras Venture Partners** VC firm **2** rounds together](https://millionrounds.com/fund/hatteras-venture-partners)[**New Enterprise Associates** VC firm **2** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**RiverVest** VC firm **2** rounds together](https://millionrounds.com/fund/rivervest-venture-partners)[**Sound Bioventures** VC firm **2** rounds together](https://millionrounds.com/fund/sound-bioventures) ## Recently backed The latest companies Pappas Capital put money into. [**Ribometrix** $30M · Nov 2018](https://millionrounds.com/company/ribometrix)[**Milestone Pharmaceuticals** $80M · Oct 2018](https://millionrounds.com/company/milestone-pharmaceuticals)[**Kezar Life Sciences** $50M · Jul 2017](https://millionrounds.com/company/kezar-life-sciences) ## Quick answers about Pappas Capital ### What does Pappas Capital invest in? Pappas Capital invests most often at Series A and Series B (91% of the rounds on record), in sectors such as Molecules, Pharmaceuticals and Medicine. ### How active is Pappas Capital? 12 investments on record, 2 of them in the last 12 months. The most recent was in Oct 2026. ### What has Pappas Capital invested in recently? Its most recent investments on record: Altay Therapeutics, Inc. (Series A, Oct 2026), Breye Therapeutics (Series A, Sept 2026) and Reneo Pharmaceuticals (Series A, May 2019). ### How big are Pappas Capital's cheques? The median round it joins is $52M. ### Does Pappas Capital lead rounds? Rarely, if at all: none of its 12 investments on record names it as the lead. ### Where does Pappas Capital invest? Most of the companies it backs are in the United States (75%), Denmark (8%) and Canada (8%). ### Is Pappas Capital investing now? Yes: it is actively investing, with 2 investments in the last 12 months. ### Who does Pappas Capital invest alongside? Most often Alexandria Real Estate Equities (2 rounds together), Hatteras Venture Partners (2 rounds together) and New Enterprise Associates (2 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=pappas-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=pappas-capital)